Breast MRI: EUSOBI recommendations for women's information
Mann RM (1), Balleyguier C (2), Baltzer PA (3), Bick U (4), Colin C (5), Cornford E (6), Evans A (7), Fallenberg E (4), Forrai G (8), Fuchsjäger MH (9), Gilbert FJ (10), Helbich TH (3), Heywang-Köbrunner SH (11), Camps-Herrero J (12), Kuhl CK (13), Martincich L (14), Pediconi F (15), Panizza P (16), Pina LJ (17), Pijnappel RM (18), Pinker-Domenig K (3), Skaane P (19), Sardanelli F (20); European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition.
(1) Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
(2) Department of Radiology, Gustave-Roussy Institute, Villejuif, France.
(3) Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria.
(4) Clinic of Radiology, Charité, Universitätsmedizin Berlin, Berlin, Germany.
(5) Radiology Unit, Hospices Civils de Lyon, Centre Hospitalo-Universitaire Lyon Sud, Pierre Bénite Cedex, France.
(6) Nottingham Breast Institute, Nottingham University Hospitals, Nottingham, UK.
(7) Dundee Cancer Centre, Clinical Research Centre, Ninewells Hospital and Medical School, Dundee, UK.
(8) MHEK Teaching Hospital University Semmelweis, Budapest, Hungary.
(9) Department of Radiology, Medical University of Graz, Graz, Austria.
(10) Department of Radiology, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
(11) National Reference Centre Mammography, Munich, Munich, Germany.
(12) Department of Radiology, Hospital de la Ribera, Alzira, Valencia, Spain.
(13) University Hospital of Aachen, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany.
(14) Radiology Unit, IRCCS-FPO, Candiolo, Turin, Italy.
(15) Department of Radiological, Oncological and Pathological Sciences, Sapienza University, Rome, Italy.
(16) Department of Radiology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
(17) Department of Radiology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
(18) Department of Imaging, University Medical Centre Utrecht, Utrecht, The Netherlands.
(19) Department of Radiology, Oslo University Hospital Ullevaal, University of Oslo, Oslo, Norway.
(20) Department of Biomedical Sciences for Health, Università degli Studi di Milano, Radiology Unit, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy.
This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination.
The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed.
Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives).
These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna-The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI.
CITATION Eur Radiol. 2015 Dec;25(12):3669-78. doi: 10.1007/s00330-015-3807-z. Epub 2015 May 23